JP Patent

JP2015038139A — 薬物過量摂取の治療のためのモルヒナン誘導体

Assigned to Alkermes Pharma Ireland Ltd · Expires 2015-02-26 · 11y expired

What this patent protects

【課題】薬物毒性および薬物過量摂取、特にオピオイドの過量摂取の治療に有用なモルヒナン化合物の提供。 【解決手段】下記の式で表される化合物-1のリンゴ酸塩。 【選択図】なし

USPTO Abstract

【課題】薬物毒性および薬物過量摂取、特にオピオイドの過量摂取の治療に有用なモルヒナン化合物の提供。 【解決手段】下記の式で表される化合物-1のリンゴ酸塩。 【選択図】なし

Drugs covered by this patent

Patent Metadata

Patent number
JP2015038139A
Jurisdiction
JP
Classification
—
Expires
2015-02-26
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Pharma Ireland Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.